INTERNATIONAL PATENT: ZHONGSHAN INNOVATION BIOPHARMACEUTICAL CO., LTD., 中山医诺维申新药研发有限公司 FILES APPLICATION FOR "COMPOUND FOR DOUBLE TARGETING OF FIBROBLAST ACTIVATION PROTEIN AND INTEGRIN SUBTYPE, PREPARATION THEREFOR AND USE THEREOF"

GENEVA, Oct. 26 -- ZHONGSHAN INNOVATION BIOPHARMACEUTICAL CO., LTD. (Room 13-018, 13th Floor, No.1 Jiankang Road, Torch Development ZoneZhongshan, Guangdong 528437), 中山医诺维申新药研发有限公司 (中国广东省中山市火炬开发区健康路1号十三楼13-018室) filed a patent application (PCT/CN2025/089172) for "COMPOUND FOR DOUBLE TARGETING OF FIBROBLAST ACTIVATION PROTEIN AND INTEGRIN SUBTYPE, PREPARATION THEREFOR, AND USE THEREOF" on Apr 16, 2025. With publication no. WO/2025/218677, the details related to the patent application was published on ...